Accelerating Medical Device Innovation with Regulatory Science Tools
2022 Webinar Series
The National Heart, Lung, and Blood Institute (NHLBI) Small Business Program is partnering with the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) for a three-part webinar series presenting the use of regulatory science tools to accelerate medical device innovation.
The rate of technology development continues to accelerate, and it is vital that the science for evaluating the benefits and risks of new products keeps pace. FDA is helping to ensure that device developers have the right test methods to evaluate new innovations to speed development and patient access. Regulatory Science Tools expand the scope of innovative science-based approaches to improve the development and assessment of emerging medical technologies.
These tools reduce the need for device developers to design ad-hoc test methods and allow them to focus their limited resources on technology development and not method development. They represent an important contribution to reducing risk in all stages of product development and are particularly important to the early inventors and innovators.
Attendees will have the unique opportunity to hear experiences and use cases from distinguished leaders in the small business and med tech innovation space including NHLBI, CDRH, and the Small Business Education and Entrepreneurial Development (SEED) office.